An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Tandem Diabetes Care, Inc. (TNDM) will present at investor conferences on May 15 and May 29, 2024, providing company updates. The presentations will be webcast live and archived for 30 days.
Tandem Diabetes Care, Inc. (TNDM) parteciperà a conferenze per investitori il 15 e il 29 maggio 2024, fornendo aggiornamenti sulla compagnia. Le presentazioni saranno trasmesse in diretta via web e archiviate per 30 giorni.
Tandem Diabetes Care, Inc. (TNDM) se presentará en conferencias de inversores el 15 y el 29 de mayo de 2024, proporcionando actualizaciones de la empresa. Las presentaciones serán transmitidas en vivo por internet y archivadas durante 30 días.
탠덤 다이어베스 케어, Inc. (TNDM)는 2024년 5월 15일과 29일에 투자자 회의에 참석하여 회사 업데이트를 제공할 예정입니다. 이 프레젠테이션은 라이브 웹캐스트로 진행되며 30일간 보관됩니다.
Tandem Diabetes Care, Inc. (TNDM) présentera lors de conférences d'investisseurs les 15 et 29 mai 2024, en fournissant des mises à jour sur l'entreprise. Les présentations seront diffusées en direct sur Internet et archivées pendant 30 jours.
Tandem Diabetes Care, Inc. (TNDM) wird am 15. und 29. Mai 2024 auf Investorenkonferenzen präsentieren und Unternehmensupdates geben. Die Präsentationen werden live im Internet übertragen und 30 Tage lang archiviert.
Positive
None.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:
BofA Securities Health Care Conference 2024 on Wednesday, May 15, 2024 at 1:00pm Eastern Time (10:00am Pacific Time), and
Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 at 12:20pm Eastern Time (9:20am Pacific Time).
The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.
Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.
tandem diabetes care, inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. the company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. tandem manufactures and sells the t:slim x2™ insulin pump, the only pump capable of remote feature updates using a personal computer, and the t:flex® insulin pump, the first pump designed for people with greater insulin requirements. tandem is based in san diego, california. safety information please note that this account is not intended to be used for product support or medical advice. if you are having a medical emergency, please dial 911. if you are having an issue with one of our products and need immediate assistance, please call our 24 hour customer support team at 877-801-6901 and press 1 twice. tandem insulin pumps are intended for the subcutan
